This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Researchers from Rutgers Health and RWJBarnabas Health have developed an artificial intelligence (AI) technology that transforms basic electrocardiogram (ECG) readings of electrical activity into sophisticated heart motion signals normally obtained via echocardiogram, potentially improving how heart disease is detected and monitored.
Researchers used an AI-enabled digital stethoscope that captures electrocardiogram ( ECG ) data and heart sounds to identify twice as many cases of peripartum cardiomyopathy as compared to regular care, according to a news release from the American Heart Association.
This is radically simplifying the patient pathway for Electrocardiogram (ECG) tests. For instance, the average waiting time for an echocardiogram at Turin’s Molinette Hospital was 31 days in 2016 and an even longer 53 days for a Holter ECG. Integrating AI-powered ECG analysis into these networks can enhance patient care.
The last section is a detailed discussion of the research on aVR in both STEMI and NonSTEMI. An echocardiogram on day 3 showed no wall motion abnormality (but of course, these can resolved with reperfusion, and the more time it has to resolve from "stunning", the more likely it is to be resolved). It was stented. References : 1.
Workup including routine laboratory results, 12-lead electrocardiogram (ECG), echocardiogram, and coronary angiogram was non-specific. Further research is warranted to investigate the interactions between lacosamide and SCN5A variants. Of note, the patient had a family history of sudden cardiac death.
Laboratory tests showed markedly elevated troponin I levels (>50 ng/ml) and atrial fibrillation, along with inferior wall ST elevation on the electrocardiogram. A 2D echocardiogram revealed an ejection fraction of 43%, hypokinesia of the anterior and intraventricular septum from base to apex, and severe mitral stenosis.
I remember Allie well from her days in the Research volunteer program at Hennepin. A formal echocardiogram was completed the next day and again showed a normal ejection fraction without any focal wall motion abnormalities to suggest CAD. Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias.
His cardiac testing completed to date consist of an electrocardiogram and an echocardiogram performed Feb 16th, 2023 that were both normal. What follows is data produced since the vaccine rollout that is relevant to Mr. Smith’s case. The pain resolved a few weeks later.
Abnormal Electrocardiogram (ECG): Defined (San Fran syncope rule) as any new changes when compared to the last ECG or presence of non-sinus rhythm. Results : Electrocardiograms (99%), telemetry (95%), cardiac enzymes (95%), and head computed tomography (CT) (63%) were the most frequently obtained tests.
The study assessed the model's ability to analyze heart sound and single-lead electrocardiogram (ECG) data recorded via a digital stethoscope to identify individuals with actionably low EF (EF40%). Study Highlights AI's Role in Early Detection The study enrolled 2,960 adults from four U.S. healthcare networks undergoing echocardiography.
Retrospective analysis of NSCLC patients with 1 echocardiogram post-osimertinib between 2007 and 2022 was performed. Osimertinib is first-line treatment for epidermal growth factor (EGFR)-mutated non-small cell lung cancer (NSCLC) and has been associated with cardiotoxicity.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content